What You Should Know:
– 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
– The bankruptcy…
Continue Reading
Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process. In a press release, the company said…
Continue Reading
Top News
Struggling consumer genetic testing company 23andMe considers selling its Lemonaid telehealth business.
23andMe acquired the business in 2021 for $400 million.
23andMe’s entire board resigned last September over differences in the company’s direction. It announced…
American Heart Association Ventures Invests in MDisrupt
Lisa Suennen, Managing Partner of American Heart Association Ventures and Longtime Healthcare Veteran, Joins the MDisrupt Board
MDisrupt’s Marketplace will be Made Available to Thousands of the American Heart…
What You Should Know:
– 23andMe Holding Co., a leading player in preventative health and therapeutics, and Nightingale Health, a pioneer in biomarker testing, announced a collaboration to pilot Nightingale’s blood metabolomics panel with a…
Continue Reading
Telemental health company Brightside Health announced it raised $33 million dollars in Series C funding powered by healthcare-focused venture capital firm S32. Kennedy Lewis, Time BioVentures, and 23andMe founder Anne Wojcicki participated in the round….
Continue Reading
What You Should Know:
– 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for 23ME-01473 (referred to…
Continue Reading
What You Should Know:
– 23andMe has launched 23andMe+ Total Health, a comprehensive prevention-based health membership.
– Total Health provides clinical-grade exome sequencing, biannual blood testing, genetics-based clinical care, and access to clinicians trained in genetics.
Comprehensive,…
Continue Reading
By Jacqueline LaPointe
November 01, 2023 – Minority groups are at risk following the recent 23andMe data breach that has resulted in health data and personally identifiable information (PII) of certain minority groups exposed on the…
Continue Reading
What You Should Know:
– 23andMe, a genetic health and biopharmaceutical company launched Health Action Plan, a new digital tool for 23andMe+ members that draws on results from genetic reports, health history survey data, as…
Continue Reading
